APVO logo

Aptevo Therapeutics Inc. (APVO)

Profile

Full Name

Aptevo Therapeutics Inc.

Ticker

NASDAQ: APVO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 20, 2016

Indexes

Not included

Website

https://aptevotherapeutics.com

Employees

37

Key Details

Price

$1.41(-1.40%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$1747.68(24.56% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.41
    APVO price is $1.41

    30-Day Relative Volume

    1.27
    APVO 30-day relative volume is 1.27

    Price Performance

    Price Most Recent Change

    -1.4%
    APVO price was down -1.4% on Oct 6, 2025

    Price YTD Change

    -98.36%
    APVO price is down -98.36% since January 1st

    Price 1-Year Change

    -98.87%
    APVO price is down -98.87% year-on-year

    Price 3-Year Change

    -100%
    APVO price is down -100% over the past 3 years

    Price Range

    Price All-Time High

    $3778913.50
    APVO price is currently -100.00% below its historical high of $3778913.50

    Price 3-Year Low

    $1.32
    APVO price is currently +6.82% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $4.55M
    APVO market cap is $4.55 million

    Market Cap 3-Year Change

    -77.77%
    APVO market cap is down -77.77% over the past 3 years

    Market Cap All-Time High

    $34186.93B
    APVO market cap is currently -100.00% below its historical high of $34186.93 billion

    Market Cap Sector Percentile

    8.5%
    APVO market cap is higher than 8.5% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +13918.26%
    APVO shares outstanding is up +13918.26% year-on-year

    Shares Outstanding 3-Year Change

    +1612000%
    APVO shares outstanding is up +1612000% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.64
    APVO beta is 0.64

    200-day SMA

    $29.57
    APVO price is currently -95.23% below its 200-day simple moving average

    50-day SMA

    $1.88
    APVO price is currently -24.83% below its 50-day simple moving average

    14-Day RSI

    39.54
    APVO 14-day relative strength index is 39.54

    Volume

    1.27
    APVO 30-day relative volume is 1.27

    ATR

    $0.19
    APVO average true range is $0.19

    10-day Historical Volatility

    83.88%
    APVO 10-day historical volatility is 83.88%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    APVO annual revenue is $0.00

    Revenue Analysts Estimate

    -
    APVO annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    APVO annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.74%
    APVO annual revenue is higher than 28.74% of companies in Healthcare sector

    EPS

    EPS

    -$1747.68
    APVO annual earnings per share is -$1747.68

    EPS Analysts Estimate

    -$14.18
    APVO annual earnings per share is currently >+9900.00% higher than the consensus analysts' forecast

    EPS 1-Year Change

    +24.56%
    APVO annual earnings per share is up +24.56% year-on-year

    EPS Sector Percentile

    0.84%
    APVO annual earnings per share is higher than 0.84% of companies in Healthcare sector

    Profit

    Gross Profit

    -$352.00K
    APVO annual gross profit is -$352.00 thousand

    Gross Margin

    -
    APVO annual gross profit margin value is unknown

    Operating Profit

    -$24.60M
    APVO annual operating income is -$24.60 million

    Operating Margin

    -
    APVO annual operating profit margin value is unknown

    Net Income

    -$24.13M
    APVO annual net profit is -$24.13 million

    Net Margin

    -
    APVO annual net profit margin value is unknown

    Expenses

    Total Expenses

    $24.60M
    APVO annual total expenses is $24.60 million

    Operating Expenses

    $24.60M
    APVO annual total operating expenses is $24.60 million

    Cost Of Goods Sold

    $352.00K
    APVO annual cost of goods sold is $352.00 thousand

    Selling, General & Administrative Expenses

    $10.22M
    APVO annual SG&A is $10.22 million

    Depreciation & Amortization

    $352.00K
    APVO annual D&A is $352.00 thousand

    Interest Expense

    $0.00
    APVO annual interest expense is $0.00

    Income Tax

    $0.00
    APVO annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$24.60M
    APVO annual earnings before interest & taxes is -$24.60 million

    EBITDA

    -$24.25M
    APVO annual EBITDA is -$24.25 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $15.59M
    APVO annual total assets is $15.59 million

    Non Current Assets

    $4.93M
    APVO annual long term assets is $4.93 million

    Current Assets

    $10.66M
    APVO annual total current assets is $10.66 million

    Cash and Cash Equivalents

    $8.71M
    APVO annual cash & cash equivalents is $8.71 million

    Accounts Receivable

    -
    APVO annual accounts receivable value is unknown

    Inventory

    $0.00
    APVO annual inventory is $0.00

    Liabilities

    Total Liabilities

    $10.84M
    APVO annual total liabilities is $10.84 million

    Long Term Liabilities

    $4.63M
    APVO annual total long term liabilities is $4.63 million

    Current Liabilities

    $6.21M
    APVO annual current liabilities is $6.21 million

    Accounts Payable

    $3.05M
    APVO annual accounts payable is $3.05 million

    Debt

    Total Debt

    $4.63M
    APVO annual total debt is $4.63 million

    Total Debt 1-Year Change

    -14.23%
    APVO annual total debt is down -14.23% year-on-year

    Long Term Debt

    $4.63M
    APVO annual long term debt is $4.63 million

    Short Term Debt

    $0.00
    APVO annual short term debt is $0.00

    Equity & Capital

    Shareholders Equity

    $4.75M
    APVO annual stockholders equity is $4.75 million

    Book Value

    $95.10M
    APVO annual book value is $95.10 million

    Retained Earnings

    -$247.58M
    APVO annual retained earnings is -$247.58 million

    Working Capital

    $4.45M
    APVO annual working capital is $4.45 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$23.79M
    APVO annual cash from operations is -$23.79 million

    Cash From Operations 1-Year Change

    -102.77%
    APVO annual cash from operations is down -102.77% year-on-year

    Cash From Investing

    $0.00
    APVO annual cash from investing is $0.00

    Cash From Investing 1-Year Change

    0%
    APVO annual cash from investing has remained unchanged year-on-year

    Cash From Financing

    $15.60M
    APVO annual cash from financing is $15.60 million

    Cash From Financing 1-Year Change

    +160%
    APVO annual cash from financing is up +160% year-on-year

    CAPEX

    CAPEX

    $0.00
    APVO annual capital expenditures is $0.00

    CAPEX 1-Year Change

    0%
    APVO annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free Cash Flow

    -$23.79M
    APVO annual free cash flow is -$23.79 million

    Free Cash Flow 1-Year Change

    -102.77%
    APVO annual free cash flow is down -102.77% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    APVO annual gross profit margin value is unknown

    Operating Margin

    -
    APVO annual operating profit margin value is unknown

    Net Margin

    -
    APVO annual net profit margin value is unknown

    ROA & ROE

    ROA

    -119.36%
    APVO annual return on assets is -119.36%

    ROE

    -284.28%
    APVO annual return on equity is -284.28%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    APVO price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    APVO price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    0.70
    APVO price to book ratio is 0.70

    PB Ratio Sector Percentile

    27.93%
    APVO price to book ratio is higher than 27.93% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    APVO price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    APVO price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    -$654.88K
    APVO enterprise value is -$654.88 thousand

    Enterprise Value Sector Percentile

    8.41%
    APVO enterprise value is higher than 8.41% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.03
    APVO EV/EBITDA is 0.03

    EV/EBITDA Sector Percentile

    66.97%
    APVO EV/EBITDA is higher than 66.97% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    1.72
    APVO annual current ratio is 1.72

    Quick Ratio

    1.72
    APVO annual quick ratio is 1.72

    Leverage

    Debt To Equity

    0.97
    APVO annual debt to equity ratio is 0.97

    Interest Coverage Ratio

    -
    APVO annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    APVO piotroski f-score value is unknown

    Altman Z-Score

    -26.84
    APVO altman z-score is -26.84

    Analyst ratings

    Recent major analysts updates

    May 13, 22 Piper Sandler
    Overweight
    May 28, 21 Roth Capital
    Buy
    Nov 25, 20 Roth Capital
    Buy
    Nov 25, 20 PiperJaffray
    Overweight
    Nov 11, 20 Piper Sandler
    Overweight
    Apr 11, 18 Roth Capital
    Buy
    Sep 9, 16 Piper Sandler
    Overweight

    Institutional Ownership

    Screeners with APVO included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biggest stock gainers today
    • What is the ticker symbol for Aptevo Therapeutics Inc.?
    • Does Aptevo Therapeutics Inc. pay dividends?
    • What sector is Aptevo Therapeutics Inc. in?
    • What industry is Aptevo Therapeutics Inc. in?
    • What country is Aptevo Therapeutics Inc. based in?
    • When did Aptevo Therapeutics Inc. go public?
    • Is Aptevo Therapeutics Inc. in the S&P 500?
    • Is Aptevo Therapeutics Inc. in the NASDAQ 100?
    • Is Aptevo Therapeutics Inc. in the Dow Jones?
    • When was Aptevo Therapeutics Inc.'s last earnings report?
    • When does Aptevo Therapeutics Inc. report earnings?

    What is the ticker symbol for Aptevo Therapeutics Inc.?

    The ticker symbol for Aptevo Therapeutics Inc. is NASDAQ:APVO

    Does Aptevo Therapeutics Inc. pay dividends?

    No, Aptevo Therapeutics Inc. does not pay dividends

    What sector is Aptevo Therapeutics Inc. in?

    Aptevo Therapeutics Inc. is in the Healthcare sector

    What industry is Aptevo Therapeutics Inc. in?

    Aptevo Therapeutics Inc. is in the Biotechnology industry

    What country is Aptevo Therapeutics Inc. based in?

    Aptevo Therapeutics Inc. is headquartered in United States

    When did Aptevo Therapeutics Inc. go public?

    Aptevo Therapeutics Inc.'s initial public offering (IPO) was on July 20, 2016

    Is Aptevo Therapeutics Inc. in the S&P 500?

    No, Aptevo Therapeutics Inc. is not included in the S&P 500 index

    Is Aptevo Therapeutics Inc. in the NASDAQ 100?

    No, Aptevo Therapeutics Inc. is not included in the NASDAQ 100 index

    Is Aptevo Therapeutics Inc. in the Dow Jones?

    No, Aptevo Therapeutics Inc. is not included in the Dow Jones index

    When was Aptevo Therapeutics Inc.'s last earnings report?

    Aptevo Therapeutics Inc.'s most recent earnings report was on August 9, 2018

    When does Aptevo Therapeutics Inc. report earnings?

    The date for Aptevo Therapeutics Inc.'s next earnings report has not been announced yet
    On this page